GC Therapeutics: Funding, Investors & Team (Sep 2026)
GC Therapeutics utilizes synthetic biology to efficiently and effectively program patient-derived stem cells into different types of cells. They have successfully engineered cells for multiple uses in a single process and have also developed specialized cells called SuperCells™ tailored to specific conditions. The foundational technology for GC Therapeutics was created and perfected in Professor George Church's lab at Harvard Medical School. The team at GC Therapeutics, made up of committed biologists and tissue engineers, aims to make this innovative approach accessible to patients.
GC Therapeutics has raised $65.0M across 1 funding round on record, the most recent a Series A of $65.0M announced in Sep 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
GC Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2024.
GC Therapeutics Funding Rounds
GC Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
GC Therapeutics Funding Compared to Other Biotechnology Startups
GC Therapeutics' latest round of $65.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GC Therapeutics in Biotechnology and Boston
Companies Similar to GC Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
GC Therapeutics Funding FAQs
What does GC Therapeutics do?
GC Therapeutics utilizes synthetic biology to efficiently and effectively program patient-derived stem cells into different types of cells. They have successfully engineered cells for multiple uses in a single process and have also developed specialized cells called SuperCells™ tailored to specific conditions. The foundational technology for GC Therapeutics was created and perfected in Professor George Church's lab at Harvard Medical School. The team at GC Therapeutics, made up of committed biologists and tissue engineers, aims to make this innovative approach accessible to patients.
How much funding has GC Therapeutics raised?
GC Therapeutics has raised $65.0M across 1 round on record. The most recent is a Series A of $65.0M announced in Sep 2024.
When did GC Therapeutics last raise funding?
GC Therapeutics' most recent funding round on record is a Series A of $65.0M, announced in Sep 2024.
Who founded GC Therapeutics?
FundedIQ lists Parastoo Khoshakhlagh (Founder) at GC Therapeutics.
Where is GC Therapeutics headquartered?
GC Therapeutics is based in Boston, Massachusetts, United States.
How many employees does GC Therapeutics have?
GC Therapeutics is in the 11-50 employee band.
How does GC Therapeutics' funding compare to other Biotechnology startups?
GC Therapeutics' latest round of $65.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's GC Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GC Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.